Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Reactogenicity of mRNA and non-mRNA Based COVID-19 Vaccines Among Lactating Mother and Baby Dyads

Version 1 : Received: 13 May 2022 / Approved: 17 May 2022 / Online: 17 May 2022 (10:31:51 CEST)

A peer-reviewed article of this Preprint also exists.

Jacob-Chow, B.; Vasundhara, K.L.; Cheang, H.K.; Lee, L.Y.; Low, J.M.; Amin, Z. Reactogenicity of mRNA- and Non-mRNA-Based COVID-19 Vaccines among Lactating Mother and Child Dyads. Vaccines 2022, 10, 1094. Jacob-Chow, B.; Vasundhara, K.L.; Cheang, H.K.; Lee, L.Y.; Low, J.M.; Amin, Z. Reactogenicity of mRNA- and Non-mRNA-Based COVID-19 Vaccines among Lactating Mother and Child Dyads. Vaccines 2022, 10, 1094.

Abstract

The aims of the study are: a) Describe the reactogenicity of WHO-approved two mRNA (Pfizer-BioNTech, Moderna) and two non-RNA vaccines (Oxford-AstraZeneca, Sinovac) among lactating mother and baby pairs; and b) compare and contrast the reactogenicity between mRNA and non-mRNA vaccines. A cross-sectional, self-reported survey was conducted amongst 1784 lactating women who received COVID-19 vaccinations. The most common maternal adverse reaction was a local reaction at the injection site; the largest minority of respondents, 43.7% (780/1784), reported experiencing worse symptoms when receiving the second dose compared to the first dose. There were no major reported adverse effects or behavioural changes in the breastfed infants. Among the respondents who received non-mRNA COVID-19 vaccinations, a majority reported no change in lactation but those who did more commonly reported an increase in milk supply, decrease in milk supply and pain in the breast. The more commonly reported lactation changes (fluctuations in breastmilk supply and pain in the breast) for the non-mRNA vaccines were similar to that of respondents who received mRNA vaccines. Our study, with a large cohort and wide geographical and racial mix, further augments earlier reported findings that COVID-19 vaccines are safe for breastfeeding mothers and her children.

Keywords

COVID-19 vaccines; SARS-CoV2; lactation; mother-child dyads; reactogenicity

Subject

Medicine and Pharmacology, Pediatrics, Perinatology and Child Health

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.